Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - V2X Inc (NYSE: VVX) reported first quarter EPS of $0.80, $0.12 better than the analyst estimate of $0.68. Revenue for the quarter came in at $943.5M versus the consensus estimate of $847.83M.
Guidance
V2X Inc sees FY 2023 EPS of $3.80-$4.30 versus the analyst consensus of $1.87.
V2X Inc sees FY 2023 revenue of $3.80B-$3.90B versus the analyst consensus of $3.87B.
V2X Inc's stock price closed at $44.80. It is up 0.79% in the last 3 months and up 23.59% in the last 12 months.
V2X Inc saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See V2X Inc's stock price’s past reactions to earnings here.
According to InvestingPro, V2X Inc's Financial Health score is "good performance".
Check out V2X Inc's recent earnings performance, and V2X Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar